• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,499.77 481.98
( 0.63%)
Global Indices
Nasdaq
49,315.95 353.04
(0.72%)
Dow Jones
7,281.26 59.51
(0.82%)
Hang Seng
59,594.47 309.55
(0.52%)
Nikkei 225
10,219.44 -144.49
(-1.39%)
Forex
USD-INR
95.09 0.27
(0.28%)
EUR-INR
111.34 0.19
(0.17%)
GBP-INR
128.90 0.20
(0.16%)
JPY-INR
0.61 0.00
(0.29%)

EQUITY - MARKET SCREENER

Anlon Technology Solutions Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
77891
INE0LR101013
94.0227643
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ANLON
58.14
377.51
EPS(TTM)
Face Value()
Div & Yield %
10.38
10
0
 

Emcure Pharmaceuticals consolidated net profit rises 28.81% in the March 2026 quarter
May 05,2026
Net profit of Emcure Pharmaceuticals rose 28.81% to Rs 243.40 crore in the quarter ended March 2026 as against Rs 188.96 crore during the previous quarter ended March 2025. Sales rose 16.70% to Rs 2469.70 crore in the quarter ended March 2026 as against Rs 2116.25 crore during the previous quarter ended March 2025.

For the full year,net profit rose 35.67% to Rs 924.36 crore in the year ended March 2026 as against Rs 681.33 crore during the previous year ended March 2025. Sales rose 16.56% to Rs 9203.54 crore in the year ended March 2026 as against Rs 7896.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2469.702116.25 17 9203.547896.00 17
OPM %19.4219.02 -20.2618.67 -
PBDT437.14367.83 19 1733.541365.86 27
PBT330.88270.99 22 1318.49981.73 34
NP243.40188.96 29 924.36681.33 36